An investor in NASDAQ:CHMA filed a lawsuit over alleged violations of Securities Laws by Chiasma Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Chiasma Inc (NASDAQ:CHMA) have certain options and for certain investors are short and strict deadlines running. Deadline: August 8, 2016. NASDAQ:CHMA investors should contact the […]

An investor in NASDAQ:ELRC shares filed a lawsuit in effort to halt the proposed takeover of Van Nuys, CA based Electro Rent Corporation by Platinum Equity for $13.12 per share. Investors who purchased shares of Electro Rent Corporation (NASDAQ:ELRC) and currently hold any of those NASDAQ:ELRC shares have certain options and should contact the Shareholders […]

An investigation for investors in NASDAQ:LDRH shares was announced concerning whether the takeover of medical device company LDR Holding Corp by Zimmer Biomet Holdings, Inc for $37.00 per share is unfair to NASDAQ:LDRH stockholders. Investors who purchased shares of LDR Holding Corp (NASDAQ:LDRH) and currently hold any of those NASDAQ:LDRH shares have certain options and […]

A deadline is coming up on July 11, 2016 in the lawsuit filed for certain investors in NYSE:HCP over alleged securities laws violations by Irvine, CA based HCP, Inc. Investors who purchased shares of HCP, Inc. (NYSE:HCP) have certain options and there are strict and short deadlines running. Deadline: July 11, 2016. NYSE:HCP stockholders should […]

An investigation for investors in NASDAQ:ALXN shares over potential securities laws violations by Alexion Pharmaceuticals, Inc. and certain of its directors and officers in connection certain financial statements was announced. Investors who purchased shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – […]

An investigation for investors in NASDAQ:SRNE shares was announced over potential breaches of fiduciary duties by certain officers and directors at San Diego, CA based Sorrento Therapeutics. Shares of Sorrento Therapeutics Inc (NASDAQ:SRNE) declined from as high as $23.51 per share to $4.50 per share in February 2016. Investors who purchased shares of Sorrento Therapeutics […]